CAR-T Cell Therapy for Acute Myeloid Leukemia: Where Do We Stand Now?

CAR-T Cell Therapy for Acute Myeloid Leukemia: Where Do We Stand Now?

<b>Background</b>: Patients with refractory and relapsed acute myeloid leukemia (R/R AML) face a dismal prognosis. CAR-T therapy has emerged as a potential treatment option. This study assesses the available clinical evidence on CAR-T in R/R AML, focusing on safety and efficacy outcomes....

Full description

Saved in:
Bibliographic Details
Main Authors: Pilar Lloret-Madrid, Pedro Chorão, Manuel Guerreiro, Pau Montesinos
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Current Oncology
Subjects:
acute myeloid leukemia
relapsed or refractory AML
CAR-T cell therapy
Online Access:https://www.mdpi.com/1718-7729/32/6/322
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items